RaiseTrack

This page is marked NOINDEX and hidden from search engines: fails the stub criteria, missing: investor relationships, two agreeing sources.

Araceli Biosciences Form D (2026)

Araceli Biosciences reported $2,526,065 raised in an SEC Form D filed on 2026-11-03.

Company
Araceli Biosciences
Round type
Form D
Date
2026-11-03
Amount
$2.53M
Industry
Other Technology
Location
Oregon

Summary

The SEC Form D for Araceli Biosciences, filed on 2026-11-03, reports $2,526,065 raised. The legal name on the form is Araceli Biosciences Inc. The form does not name the purchasers. Filing: https://www.sec.gov/Archives/edgar/data/1975014/000197501426000004/0001975014-26-000004-index.htm

Year of incorporation on the form: 2022. Securities on the form: debt; option, warrant or other right to acquire another security; security to be acquired upon exercise of option, warrant or other right. That wording is not stored as a round type. Earlier Form D filings, if any, are not combined. The issuer city on the form is Tigard. It is not stored as a headquarters.

This page is not indexed by search engines yet because the filing does not name the purchasers.

Investors

Sources

Last verified:

  1. https://www.sec.gov/Archives/edgar/data/1975014/000197501426000004/0001975014-26-000004-index.htm
    Type: sec filing. Accessed 2026-11-04.
    SEC Form D for Araceli Biosciences Inc. EDGAR filing date 2026-11-03. Acceptance time on the index page: 2026-11-03 12:25:39. Signed 2026-11-03 by Matt Beaudet, Chief Executive Officer. First sale 2026-10-20. A new notice, not an amendment. Total amount sold $2,526,065 of an offering amount of $4,500,000. 4 investors already invested. Issuer address city is Tigard, Oregon. Jurisdiction on the form: Delaware. Entity type on the form: Corporation. Year of incorporation on the form: 2022. The form does not name the purchasers or a round type. Street addresses and phone numbers are not published. Securities on the form: debt; option, warrant or other right to acquire another security; security to be acquired upon exercise of option, warrant or other right. That wording is not stored as a round type. Related persons use the names in the issue. Earlier Form D filings, if any, are not combined.
  2. https://buttondown.com/raisetrack/archive/raise-track-update-2026-11-04/
    Type: other verified public source. Accessed 2026-11-04.
    Raise Track Update for 2026-11-04, Section 3. Lists Araceli Biosciences in Oregon, industry Other Technology, amount raised $2,526,065.